Discovery of σ <sub>2</sub> R/TMEM97 as a Novel Biomarker for Atherosclerotic Plaques: A PET Imaging and Validation Study
σ<sub>2</sub>R/TMEM97 may serve as a potential biomarker for atherosclerotic plaques, and σ<sub>2</sub>R/TMEM97 positron emission tomography imaging may be used to monitor plaque formation and progression, as well as the efficacy of emerging therapeutic strategies for atherosclerotic plaques.
Authors
- Yiyun Huang (ORCID: https://orcid.org/0000-0002-6757-3220)
- Hai‐Yang Li (ORCID: https://orcid.org/0000-0003-0680-4133)
- Xu Gao
- Tiantian Mou (ORCID: https://orcid.org/0000-0002-0449-2706)
- Jingqi Wang
- Mingkai Yun (ORCID: https://orcid.org/0000-0002-3107-1472)
- Hongmei Jia (ORCID: https://orcid.org/0000-0002-1412-8158)
- Yi Tian (ORCID: https://orcid.org/0000-0002-4805-9859)
- Mingxin Gao (ORCID: https://orcid.org/0000-0002-3880-6064)
- Biao Hu
- X. Zhang (ORCID: https://orcid.org/0000-0002-0770-5594)
Institutions
- Capital Medical University (CN)
- Beijing Normal University (CN)
- Yale University (US)
- Beijing Anzhen Hospital (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1161/atvbaha.125.322721
- Citations
- 2
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 1.61